Shareholic Button


March 16, 2007

Fauquier ENT is 1 of 13 Sites Nationally to Participate in a New Research Study

There is a new study beginning the spring/summer of 2007 in Warrenton, VA to address the excessive dry mouth patients experience after undergoing radiation treatment for head & neck cancer. The primary objective is to assess the impact of the drug Evoxac (cevimeline) on salivary flow at a dose of 30mg three times daily. Of note, this drug and dosage has already been approved by the FDA for treatment of dry mouth in patients with Sjogren's syndrome, an autoimmune disease that causes dry mouth.

Fauquier ENT is one of only 13 sites nationally participating in this study which is coordinated by the Duke Clinical Research Institute and the American Academy of Otolaryngology-Head & Neck Surgery.

Contact our office if you would like to participate in this study. This study is anticipated to be completed end of 2008.
Fauquier blog
Fauquier ENT

Dr. Christopher Chang is a private practice otolaryngology, head & neck surgeon specializing in the treatment of problems related to the ear, nose, and throat. Located in Warrenton, VA about 45 minutes west of Washington DC, he also provides inhalant allergy testing/treatment, hearing tests, and dispenses hearing aids. Google+ Christopher Chang, MD Bio

No comments:

Post a Comment

Please be aware that our office rarely if ever replies to comments. Click to read why

Banner Map

VIDEO: How Does the Human Voicebox Work?






Amazon






ad lump in throat clogged ears